Literature DB >> 3055661

Two monoclonal antibodies (CC17, CC29) recognizing an antigen (Bo5) on bovine T lymphocytes, analogous to human CD5.

C J Howard1, K R Parsons, B V Jones, P Sopp, D H Pocock.   

Abstract

Two new monoclonal antibodies (CC17 and CC29) raised against bovine thymocytes are described. The antibodies, both of which were IgG1, recognize a molecule of approximately 67,000 molecular weight on bovine T cells. They react T cells in peripheral blood, the lymph node paracortex and the periateriolar lymphoid sheath in the spleen. Both the cortex and medulla of the thymus are stained but the medulla reacts more intensely. They do not stain B cells in peripheral blood, the ileal Peyer's patch, the cortex or the primary follicles in lymph nodes. No activity was found on cells outside the lymphoid system, i.e. monocytes, alveolar macrophages or endothelial and epithelial tissue. The antigen recognized is considered to be the bovine homologue of CD5 (T1) in humans and Lyt1 in mice. The mAbs appear to be particularly useful for detecting cells in the peripheral blood of young calves which are of the T cell lineage but do not express BoT2 or the mature pan T cell antigen recognized by mAb IL-A27 and may thus allow identification of a population of bovine lymphocytes previously described as null cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055661     DOI: 10.1016/0165-2427(88)90004-9

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  15 in total

1.  Biochemical and functional characterization of 8-10C5 (gp120,90), a novel molecule on the surface of bovine T leucocytes.

Authors:  K L O'Reilly; G A Splitter
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

2.  Three monoclonal antibodies identifying antigens on all equine T lymphocytes, and two mutually exclusive T-lymphocyte subsets.

Authors:  D P Lunn; M A Holmes; W P Duffus
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

3.  Discrimination between two subsets of porcine CD8+ cytolytic T lymphocytes by the expression of CD5 antigen.

Authors:  A Saalmüller; W Hirt; S Maurer; E Weiland
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

4.  Characterization of a bovine leucocyte differentiation antigen of 145,000 MW restricted to B lymphocytes.

Authors:  J Naessens; J Newson; N McHugh; C J Howard; K Parsons; B Jones
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  Identification of a molecule uniquely expressed on a gamma/delta TCR+ subset within bovine intestinal intraepithelial lymphocytes.

Authors:  K R Parsons; P Sopp; B V Jones; P Bland; C J Howard
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

6.  Production of bovine immunoregulatory molecules by xenogeneic hybrids.

Authors:  R A Collins; B V Jones; G Oldham
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

7.  Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.

Authors:  Nicholas Juleff; Miriam Windsor; Eric A Lefevre; Simon Gubbins; Pip Hamblin; Elizabeth Reid; Kerry McLaughlin; Peter C L Beverley; Ivan W Morrison; Bryan Charleston
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Abnormal patterns of equine leucocyte differentiation antigen expression in severe combined immunodeficiency foals suggests the phenotype of normal equine natural killer cells.

Authors:  D P Lunn; J T McClure; C S Schobert; M A Holmes
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  L-selectin expression differentiates T cells isolated from different lymphoid tissues in cattle but does not correlate with memory.

Authors:  C J Howard; P Sopp; K R Parsons
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

10.  Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo.

Authors:  B Villarreal-Ramos; M McAulay; V Chance; M Martin; J Morgan; C J Howard
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.